(5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide

C102H101BrClN21O7S2 — CID 159124578

IUPAC(5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide
SMILESCN1C(=O)C[C@@](C)(c2cc3cccc(-c4ccncc4)c3s2)N=C1N.CN1C(=O)C[C@@](C)(c2cncc(-c3cccc(Cl)c3)n2)N=C1N.CN1C(=O)[C@H](c2ccc(C3CC3)cc2)[C@@](C)(c2cc(Br)c(CO)s2)N=C1N.Cn1ccnc1CN1C(=O)C(c2ccccc2)(c2ccccc2)N=C1N.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1cccc(C(=O)NC2CCC2)c1
InChIInChI=1S/C27H26N4O2.C20H22BrN3O2S.C20H19N5O.C19H18N4OS.C16H16ClN5O/c28-26-30-27(21-11-3-1-4-12-21,22-13-5-2-6-14-22)25(33)31(26)18-19-9-7-10-20(17-19)24(32)29-23-15-8-16-23;1-20(16-9-14(21)15(10-25)27-16)17(18(26)24(2)19(22)23-20)13-7-5-12(6-8-13)11-3-4-11;1-24-13-12-22-17(24)14-25-18(26)20(23-19(25)21,15-8-4-2-5-9-15)16-10-6-3-7-11-16;1-19(11-16(24)23(2)18(20)22-19)15-10-13-4-3-5-14(17(13)25-15)12-6-8-21-9-7-12;1-16(7-14(23)22(2)15(18)21-16)13-9-19-8-12(20-13)10-4-3-5-11(17)6-10/h1-7,9-14,17,23H,8,15-16,18H2,(H2,28,30)(H,29,32);5-9,11,17,25H,3-4,10H2,1-2H3,(H2,22,23);2-13H,14H2,1H3,(H2,21,23);3-10H,11H2,1-2H3,(H2,20,22);3-6,8-9H,7H2,1-2H3,(H2,18,21)/t;17-,20+;;19-;16-/m.0.00/s1
InChIKeyKGCVTUYXHFDQGZ-DZVCCQFHSA-N
MW1912.56 g/mol
LogP14.80
Rot. Bonds18

About (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide

(5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide (PubChem CID 159124578) has the molecular formula C102H101BrClN21O7S2 and a molecular weight of 1912.56 g/mol. Its IUPAC name is (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide.

Molecular Properties

Compound Name(5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide
PubChem CID159124578
Molecular FormulaC102H101BrClN21O7S2
Molecular Weight1912.56 g/mol
Exact Mass1909.65
IUPAC Name(5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide
SMILESCN1C(=O)C[C@@](C)(c2cc3cccc(-c4ccncc4)c3s2)N=C1N.CN1C(=O)C[C@@](C)(c2cncc(-c3cccc(Cl)c3)n2)N=C1N.CN1C(=O)[C@H](c2ccc(C3CC3)cc2)[C@@](C)(c2cc(Br)c(CO)s2)N=C1N.Cn1ccnc1CN1C(=O)C(c2ccccc2)(c2ccccc2)N=C1N.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1cccc(C(=O)NC2CCC2)c1
InChIInChI=1S/C27H26N4O2.C20H22BrN3O2S.C20H19N5O.C19H18N4OS.C16H16ClN5O/c28-26-30-27(21-11-3-1-4-12-21,22-13-5-2-6-14-22)25(33)31(26)18-19-9-7-10-20(17-19)24(32)29-23-15-8-16-23;1-20(16-9-14(21)15(10-25)27-16)17(18(26)24(2)19(22)23-20)13-7-5-12(6-8-13)11-3-4-11;1-24-13-12-22-17(24)14-25-18(26)20(23-19(25)21,15-8-4-2-5-9-15)16-10-6-3-7-11-16;1-19(11-16(24)23(2)18(20)22-19)15-10-13-4-3-5-14(17(13)25-15)12-6-8-21-9-7-12;1-16(7-14(23)22(2)15(18)21-16)13-9-19-8-12(20-13)10-4-3-5-11(17)6-10/h1-7,9-14,17,23H,8,15-16,18H2,(H2,28,30)(H,29,32);5-9,11,17,25H,3-4,10H2,1-2H3,(H2,22,23);2-13H,14H2,1H3,(H2,21,23);3-10H,11H2,1-2H3,(H2,20,22);3-6,8-9H,7H2,1-2H3,(H2,18,21)/t;17-,20+;;19-;16-/m.0.00/s1
InChIKeyKGCVTUYXHFDQGZ-DZVCCQFHSA-N
XLogP14.80
TPSA399.27 Ų
H-Bond Donors7
H-Bond Acceptors24
Rotatable Bonds18
Heavy Atoms134
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001912.56
LogP ≤ 514.80
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1024

Analyze (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide?
The IUPAC name of (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide (CID 159124578) is (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide.
What is the SMILES notation for (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide?
The canonical SMILES for (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide is CN1C(=O)C[C@@](C)(c2cc3cccc(-c4ccncc4)c3s2)N=C1N.CN1C(=O)C[C@@](C)(c2cncc(-c3cccc(Cl)c3)n2)N=C1N.CN1C(=O)[C@H](c2ccc(C3CC3)cc2)[C@@](C)(c2cc(Br)c(CO)s2)N=C1N.Cn1ccnc1CN1C(=O)C(c2ccccc2)(c2ccccc2)N=C1N.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1cccc(C(=O)NC2CCC2)c1.
What is the InChIKey of (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide?
The InChIKey is KGCVTUYXHFDQGZ-DZVCCQFHSA-N. The full InChI is InChI=1S/C27H26N4O2.C20H22BrN3O2S.C20H19N5O.C19H18N4OS.C16H16ClN5O/c28-26-30-27(21-11-3-1-4-12-21,22-13-5-2-6-14-22)25(33)31(26)18-19-9-7-10-20(17-19)24(32)29-23-15-8-16-23;1-20(16-9-14(21)15(10-25)27-16)17(18(26)24(2)19(22)23-20)13-7-5-12(6-8-13)11-3-4-11;1-24-13-12-22-17(24)14-25-18(26)20(23-19(25)21,15-8-4-2-5-9-15)16-10-6-3-7-11-16;1-19(11-16(24)23(2)18(20)22-19)15-10-13-4-3-5-14(17(13)25-15)12-6-8-21-9-7-12;1-16(7-14(23)22(2)15(18)21-16)13-9-19-8-12(20-13)10-4-3-5-11(17)6-10/h1-7,9-14,17,23H,8,15-16,18H2,(H2,28,30)(H,29,32);5-9,11,17,25H,3-4,10H2,1-2H3,(H2,22,23);2-13H,14H2,1H3,(H2,21,23);3-10H,11H2,1-2H3,(H2,20,22);3-6,8-9H,7H2,1-2H3,(H2,18,21)/t;17-,20+;;19-;16-/m.0.00/s1.
What are the key properties of (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide?
(5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide has a molecular weight of 1912.56 g/mol, XLogP of 14.80, 18 rotatable bonds, 7 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (5R,6S)-2-amino-6-[4-bromo-5-(hydroxymethyl)thiophen-2-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[6-(3-chlorophenyl)pyrazin-2-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(7-pyridin-4-yl-1-benzothiophen-2-yl)-5H-pyrimidin-4-one;2-amino-3-[(1-methylimidazol-2-yl)methyl]-5,5-diphenylimidazol-4-one;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclobutylbenzamide is sourced from PubChem (CID 159124578), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).